Use of perlecan and fragments thereof to reduce the risk of death in stroke patients
NZ835542APending Publication Date: 2026-07-31STREAM BIOMEDICAL INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- NZ835542
- Authority / Receiving Office
- NZ · NZ
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-08-05
- Filing Date
- 2021-07-26
- Publication Date
- 2026-07-31
Smart Images
Figure 1_ABST
Abstract
The present disclosure is directed to the use of perlecan compositions to reduce the risk of mortality in subjects due to neurological injury such as stroke, including large vessel occlusion, and traumatic brain injury. The disclosure is also directed to the use of perlecan compositions to reduce mortality in stroke patients treated with tPA.
Need to check novelty before this filing date? Find Prior Art